Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease

American Journal of Cardiology

Volumn 95, Issue 4, 2005, Pages 474-478

  Law, Yuk M ^a   Keller, Bradley B ^b   Feingold, Brian M ^b   Boyle, Gerard J ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; INFANT; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELIABILITY; SENSITIVITY AND SPECIFICITY;

EID: 13844272242     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.10.014     Document Type: Article

References (18)

1. P.A. McCullough, R.M. Nowak, J. McCord, J.E. Hollander, H.C. Herrmann, P.G. Steg, P. Duc, A. Westheim, T. Omland, C.W. Knudsen B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) multinational study Circulation 106 2002 416 422
2. A.S. Maisel, P. Krishnaswamy, R.M. Nowak, J. McCord, J.E. Hollander, P. Duc, T. Omland, A.B. Storrow, W.T. Abraham Breathing Not Properly Multinational Study Investigators Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
3. K. Maeda, T. Takayoshi, A. Wada, T. Hisanaga, M. Kinoshita Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am Heart J 135 1998 825 832
4. A. Clerico, G. Iervasi, M.G. Del Chicca, M. Emdin, S. Maffei, M. Nannipieri, L. Sabatino Forini F, Manfredi C, Donato L Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure J Endocrinol Invest 21 1998 170 179
5. V. Cheng, R. Kazanagra, A. Garcia, L. Lenert, P. Krishnaswamy, N. Gardetto, P. Clopton, A. Maisel A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J Am Coll Cardiol 37 2001 386 391
6. P.A. Poole-Wilson Tailored treatment for heart failure: an emerging concept Am Heart J 138 1999 1005 1006
7. D.R. Murdoch, T.A. McDonagh, J. Byrne, L. Blue, R. Farmer, J.J. Morton, H.J. Dargie Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy Am Heart J 138 1999 1126 1132
8. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, A.M. Richards Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
9. T. Tsutamoto, A. Wada, K. Maeda, T. Hisanaga, Y. Maeda, D. Fukai, M. Ohnishi, Y. Sugimoto, M. Kinoshita Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
10. T. Wallen, S. Landahl, T. Hedner, K. Nakao, Y. Saito Brain natriuretic peptide predicts mortality in the elderly Heart 77 1997 264 267
11. N. Arakawa, M. Nakamura, H. Aoki, K. Hiramori Plasma brain natriuretic peptide predicts survival after acute myocardial infarction J Am Coll Cardiol 27 1996 1656 1661
12. K. Maeda, T. Tsutamoto, A. Wada, N. Mabuchi, M. Hayashi, T. Tsutsui, M. Ohnishi, M. Sawaki, M. Fujii, T. Matsumoto, M. Kinoshita High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J Am Coll Cardiol 36 2000 1587 1593
13. E. Lubien, A. DeMaria, P. Krishnaswamy, P. Clopton, J. Koon, R. Kazanegra, N. Gardetto, E. Wanner, A.S. Maisel Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings Circulation 105 2002 595 601
14. P. Krishnaswamy, E. Lubien, P. Clopton, J. Koon, R. Kazanegra, E. Wanner, N. Gardetto, A. Garcia, A. DeMaria, A.S. Maisel Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction Am J Med 111 2001 274 279
15. T.S. Mir, S. Marohn, S. Laer, M. Eiselt, O. Grollmus, J. Weil Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from neonatal to adolescent period and in children with congestive heart failure Pediatrics 110 2002 e76 e81
16. A. Koch, H. Singer Normal values of B type natriuretic peptide in infants, children, and adolescents Heart 89 2003 875 878
17. N. Yoshimura, M. Yamaguchi, Y. Oshima, S. Oka, Y. Ootaki, T. Hasegawa, C. Shimazu Suppression of the secretion of atrial and brain natriuretic peptide after total cavopulmonary connection J Thorac Cardiovasc Surg 120 2000 764 769
18. H. Wahlander, A. Westerlind, G. Lindstedt, P.A. Lundberg, D. Holmgren Increased levels of brain and atrial natriuretic peptides after the first palliative operation, but not after a bidirectional Glenn anastomosis, in children with functionally univentricular hears Cardiol Young 13 2003 268 274